News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Genomatica, Inc. Appoints Jeff Lievense as Executive Vice President, Process Technology
May 1, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SAN DIEGO, April 30, 2012 (GLOBE NEWSWIRE) -- Genomatica announced that it has hired Jeff Lievense, Ph.D., as Executive Vice President, Process Technology, effective May 1, 2012.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Mergers & acquisitions
Incyte’s stars align as new CEO strikes $2B Vega takeover for blood disorder asset
June 8, 2026
·
2 min read
·
Annalee Armstrong
Deals
Roche makes up to $3B blood cancer play with Nurix’s protein degrader
June 8, 2026
·
2 min read
·
Tristan Manalac
Sickle cell disease
Fulcrum lays off 85% of staff after dropping asset, leaving 9 employees
June 5, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
Lilly and Boehringer roll back billions in German investments over health budget cuts
June 4, 2026
·
2 min read
·
Nick Paul Taylor
